| |
|
| 2002.12 |
Anhui Biochem Pharm Co., Ltd is established |
| 2003.03 |
Creation of R&D team to research and develop APIs for Anti-HIV/AIDS products |
| |
using chiral synthetic technology |
| 2006.05 |
Honored by Bureau of Science and Technology of Anhui Province for superior Hi-Tech |
| |
enterprise and CME synthetic process route |
| 2006.07 |
Honored by all provincial banks for Credible Company and AAA Grade rating |
| 2007.03 |
Lamivudine DMF number granted by US FDA (DMF No.20468) |
| 2007.04 |
Honored by Anhui Development and Reform Commission for Key Project and 861 |
| |
Project Enterprise |
| 2007.05 |
Memorandum of Understanding signed with the Clinton Foundation HIV/AIDS |
|
Initiative(USA) |
| 2007.06 |
Signed agreement with QVT Fund LP (UK) for USD $10 million capital investment |
| 2007.09 |
API manufacturing base at Anhui Taihe Industrial Park established |
| 2007.12 |
Name changed to Anhui Biochem United Pharmaceutical Co., Ltd from Anhui Biochem |
|
Pharma Co., Ltd |
| 2008.04 |
Creation of Anhui Biochem (Bio-Pharma) Co., Ltd for manufacturing finished |
| |
pharmaceutical products (from the acquisiton of a bio-pharmaceutical company) |
| 2008.05 |
Lamivudine API approved by Health Canada (DMF No.2008-036) |
| 2008.08 |
China SFDA grants GMP approval for API manufacturing facility with GMP certificate
|
| 2008.08 |
Honored by Bureau of Science and Technology of Anhui Province for |
| |
significant advancement in Science and Technology |
| 2008.09 |
China SFDA grants GMP approval to finished pharmaceutical product (FPP) |
| |
manufacturing facility |
| 2008.10 |
Products registration in Russia is started |
| 2008.10 |
China SFDA grants certificate of approval for manufacturing Entecavir API |
| |
|
